Adenocarcinoma Of Esophagus: all 354 studies

Page 4 of 4. Open to participants first (81), then studies with results posted, then the rest; newest registration first within each.

• BCX-1777 in Treating Patients With Refractory CancerCompletedNCT00073944Phase 1
• Neoadjuvant Docetaxel and Cisplatin Plus Chemoradiotherapy Followed By Surgery in Treating Patients With Locally Advanced, Resectable Esophageal CancerCompletedNCT00072033Phase 2
• Celecoxib, Paclitaxel, and Carboplatin in Treating Patients With Cancer of the EsophagusCompletedNCT00066716Phase 2
• Arsenic Trioxide in Treating Patients With Advanced Cancer of the Esophagus or Gastroesophageal JunctionTerminatedNCT00061958Phase 2
• Tezacitabine With or Without 5-Fluorouracil (5-FU) for Advanced Esophageal Cancer or Gastric CancerCompletedNCT00054873Phase 2
• Docetaxel and Capecitabine in Treating Patients With Metastatic Cancer of the Stomach or Gastroesophageal JunctionCompletedNCT00054457Phase 2
• Study of T900607-Sodium in Subjects With Previously Treated Gastric Cancer or Adenocarcinoma of the EsophagusSuspendedNCT00048529Phase 2
• Surgery With or Without Radiation Therapy and Chemotherapy in Treating Patients With Esophageal CancerCompletedNCT00047112Phase 3
• Erlotinib Hydrochloride in Treating Patients With Advanced Esophageal Cancer or Stomach CancerCompletedNCT00045526Phase 2
• Combination Chemotherapy in Treating Patients With Esophageal CancerStatus unknownNCT00041262Phase 3
• Oxaliplatin and Capecitabine in Treating Patients With Advanced Esophageal Cancer or Stomach CancerCompletedNCT00040859Phase 2
• Erlotinib in Treating Patients With Locally Advanced or Metastatic Stomach Cancer or Gastroesophageal Junction CancerCompletedNCT00032123Phase 2
• Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Cancer of the EsophagusCompletedNCT00030862Phase 2
• Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Gastrointestinal CancerWithdrawnNCT00025532Phase 1
• Radiation Therapy and Paclitaxel, Carboplatin, and Fluorouracil Followed by Esophagectomy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal JunctionCompletedNCT00022139Phase 2
• Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Esophageal CancerCompletedNCT00021320Phase 2
• Vaccine Therapy Plus Chemotherapy in Treating Patients With Metastatic or Locally Recurrent Stomach Cancer or Esophageal CancerCompletedNCT00020787Phase 3
• Irinotecan and Paclitaxel in Treating Patients With Metastatic or Recurrent Cancer of the Esophagus or StomachCompletedNCT00020761Phase 2
• DX-8951f in Treating Patients With Metastatic Stomach CancerCompletedNCT00017212Phase 2
• BMS-247550 in Treating Patients With Recurrent Metastatic Stomach Cancer That Has Been Previously Treated With ChemotherapyCompletedNCT00017056Phase 2
• BMS-247550 in Treating Patients With Metastatic Stomach Cancer Previously Treated With ChemotherapyCompletedNCT00017043Phase 2
• PNU-93914 in Treating Patients With Locally Advanced or Metastatic Cancer of the EsophagusCompletedNCT00016900Phase 2
• S0101 Gemcitabine and Irinotecan in Treating Patients With Metastatic or Recurrent Cancer of the EsophagusCompletedNCT00012363Phase 2
• Vaccine Therapy in Treating Patients With Cancer of the Gastrointestinal TractTerminatedNCT00012246Phase 2
• Chemotherapy and Radiation Therapy With or Without Fluorouracil in Treating Patients With Cancer of the Stomach Who Have Undergone SurgeryCompletedNCT00011960Phase 2
• LMB-9 Immunotoxin in Treating Patients With Advanced Pancreatic, Esophageal, Stomach, Colon, or Rectal CancerStatus unknownNCT00010270Phase 1
• Combination Chemotherapy Plus Radiation Therapy With or Without Fluorouracil in Treating Patients With Cancer of the Esophagus or StomachCompletedNCT00009880Phase 2
• Combination Chemotherapy Plus Radiation Therapy Followed By Surgery in Treating Patients With Stage I, Stage II, or Stage III Esophageal CancerTerminatedNCT00006472Phase 2
• Flavopiridol and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Esophageal Cancer That Has Not Responded to Previous PaclitaxelCompletedNCT00006245Phase 2
• Combination Chemotherapy in Treating Patients With Unresectable Locally Advanced or Metastatic Stomach CancerCompletedNCT00006081Phase 2
• Combination Chemotherapy Followed by Surgery and Intraperitoneal Chemotherapy in Treating Patients With Locally Advanced Stomach CancerCompletedNCT00006038Phase 2
• Nitrocamptothecin in Treating Patients With Locally Advanced or Metastatic Stomach Cancer That Cannot Be Removed During SurgeryStatus unknownNCT00005876Phase 2
• Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Esophageal CancerCompletedNCT00005638Phase 1
• Combination Chemotherapy in Treating Patients With Metastatic or Recurrent Cancer of the Stomach or EsophagusStatus unknownNCT00005607Phase 2
• Bryostatin 1 Plus Paclitaxel in Treating Patients With Locally Advanced or Metastatic Esophageal Cancer or Stomach CancerCompletedNCT00005599Phase 2
• Combination Chemotherapy and Interferon Alfa Followed by Surgery and/or Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Esophageal CancerTerminatedNCT00004897Phase 2
• Positron Emission Tomography in Determining Stage of Esophageal CancerCompletedNCT00004867Not applicable
• Oxaliplatin and Fluorouracil Plus Radiation Therapy in Treating Patients With Primary Esophageal or Stomach CancerCompletedNCT00004257Phase 1
• Liposomal Doxorubicin in Treating Patients With Advanced Stomach CancerStatus unknownNCT00004236Phase 2
• Docetaxel and Irinotecan in Treating Patients With Advanced Cancer of the Esophagus or StomachCompletedNCT00004235Phase 2
• S9915 Triacetyluridine, Fluorouracil, and Leucovorin in Treating Patients With Unresectable, Locally Advanced, or Metastatic Cancer of the Esophagus or StomachCompletedNCT00004233Phase 2
• Gene Therapy in Treating Patients With CancerCompletedNCT00004178Phase 1
• Oxaliplatin Combined With Fluorouracil and Leucovorin in Treating Patients With Recurrent or Metastatic Cancer of the Esophagus or StomachCompletedNCT00004127Phase 2
• Irinotecan in Treating Patients With Esophageal or Stomach CancerCompletedNCT00003748Phase 2
• Paclitaxel in Treating Patients With Metastatic, Recurrent, or Unresectable Cancer of the EsophagusStatus unknownNCT00003326Phase 2
• Combination Chemotherapy After Surgery in Treating Patients With Cancer of the Esophagus or StomachCompletedNCT00003237Phase 2
• Irinotecan in Treating Patients With Advanced Cancer of the StomachCompletedNCT00003137Phase 2
• Surgery With or Without Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the EsophagusCompletedNCT00003118Phase 3
• Combination Chemotherapy, Radiation Therapy and Surgery in Treating Patients With Cancer of the EsophagusCompletedNCT00003087Phase 2
• Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced or Metastatic Cancer of the EsophagusCompletedNCT00002984Phase 1/2
• Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the EsophagusStatus unknownNCT00002884Phase 3
• Surgery With or Without Combination Chemotherapy in Treating Patients With Cancer of the EsophagusCompletedNCT00002883Phase 3
• Combination Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the EsophagusCompletedNCT00002711Phase 1
• Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Cancer of the EsophagusCompletedNCT00002631Phase 3

← Adenocarcinoma Of Esophagus overview